Alpha 2.0
Login Register
» Journals » Nouv Rev Fr Hematol (1978)

Nouvelle Revue Française D'hématologie

Nouvelle Revue Française D'hématologie is a scientific journal, published since 1978 in English and French. The journal's country of origin is Germany and its primary focus area is hematology.
Details
Abbr. Nouv Rev Fr Hematol (1978)
Start 1978
End 1995
Frequency Bimonthly
Country Germany
Languages English
French
Specialty Hematology
Recent Articles
1.
XIVth Congress of the French Society of Hematology. Paris, France, February 3-4, 1995. Abstracts
Nouv Rev Fr Hematol (1978) . 1995 Feb; 37(1):1-124. PMID: 7716008
No abstract available.
2.
Improved detection of CD2 on formaldehyde-fixed non dehydrated cells
Cruz C, Suarez L, Rivero R
Nouv Rev Fr Hematol (1978) . 1995 Jan; 37(6):385. PMID: 8907637
No abstract available.
3.
Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation
Pico J, Bourhis J, Bennaceur A, Beaujean F, Bayle C, Ibrahim A, et al.
Nouv Rev Fr Hematol (1978) . 1995 Jan; 37(6):381-3. PMID: 8907636
No abstract available.
4.
Allogeneic transplantation of peripheral blood progenitor cells
Schmitz N
Nouv Rev Fr Hematol (1978) . 1995 Jan; 37(6):377-9. PMID: 8907635
Transplantation of autologous peripheral blood progenitor cells (PBPC) is now a well established method to reconstitute haematopoiesis after high-dose chemoradiotherapy. Allogeneic PBPCs have rarely been used as the sole measure...
5.
Selection and expansion of CD34+ cells
McNiece I
Nouv Rev Fr Hematol (1978) . 1995 Jan; 37(6):375-6. PMID: 8907634
No abstract available.
6.
Ex vivo hematopoietic cell expansion: a theoretical and technological challenge
Poloni A, Douay L
Nouv Rev Fr Hematol (1978) . 1995 Jan; 37(6):367-73. PMID: 8907633
Preclinical experience has shown that it is possible to maintain and expand hematopoietic cells in liquid culture systems by provision of optimal combinations of colony-stimulating factors (CSF). Ex vivo hematopoietic...
7.
Peripheral blood CD34+ cells: method of purification and ex vivo expansion
Bohbot A, Feugeas O, Cuillerot J, Grosse A, Rusciani I, Faradji A, et al.
Nouv Rev Fr Hematol (1978) . 1995 Jan; 37(6):359-65. PMID: 8907632
Peripheral blood stem cells (PBSC) are used increasingly for autotransplantation in the treatment of acute leukemia, lymphoma, multiple myeloma, solid tumors such as ovarian and breast carcinoma. They are collected...
8.
Ex vivo expansion of human peripheral blood progenitors
Chabannon C, Herrera-Rodriguez D, Bardin F, Mouren M, Novakovitch G, Blaise D, et al.
Nouv Rev Fr Hematol (1978) . 1995 Jan; 37(6):351-8. PMID: 8907631
Culture of human hematopoietic progenitors on a large scale could lead to several clinical applications within the near future, including the production of differentiated and functional cells, the increase in...
9.
Expansion of blood CD34 positive cells: committed precursors expansion does not affect immature hematopoietic progenitors
David S, Rice A, Vianes I, Duperray V, Dupouy M, Reiffers J
Nouv Rev Fr Hematol (1978) . 1995 Jan; 37(6):343-9. PMID: 8907630
CD34 positive (CD34+) cells contain all hematopoietic progenitors from stem cells to committed precursors. Therefore the transplantation of purified bone marrow or blood CD34+ cells is sufficient for hematopoietic recovery...
10.
In vitro expansion of CD34+ cells from peripheral blood of myeloma and lymphoma patients
Mahe B, Menard A, Accard F, Pineau D, Robillard N, Hermouet S
Nouv Rev Fr Hematol (1978) . 1995 Jan; 37(6):335-41. PMID: 8907629
We studied the feasibility of in vitro expansion of CD34+ cells from patients with multiple myeloma (MM) or follicular non Hodgkin lymphoma (NHL). CD34+ cells were selected from peripheral blood...